Bupivacaine Hydrochloride Injection
»Bupivacaine Hydrochloride Injection is a sterile solution of Bupivacaine Hydrochloride in Water for Injection.It contains not less than 93.0percent and not more than 107.0percent of the labeled amount of C18H28N2O·HCl.
Packaging and storage— Preserve in single-dose or in multiple-dose containers,preferably of Type Iglass.Injection labeled to contain 0.5%or less of bupivacaine hydrochloride may be packaged in 50-mLmultiple-dose containers.
Identification—
A: Dilute a volume of Injection,equivalent to about 50mg of bupivacaine hydrochloride,with 0.01Nhydrochloric acid to 25mL,and proceed as directed under Identification—Organic Nitrogenous Bases á181ñ,beginning with “Transfer the liquid to a separator.”The Injection meets the requirements of the test.
B: The retention time of the bupivacaine peak in the chromatogram of the Assay preparationcorresponds to that of the bupivacaine peak in the chromatogram of the Standard preparation,as obtained in the Assay.
Bacterial endotoxins á85ñ It contains not more than 2.5USP Endotoxin Units per mg of bupivacaine hydrochloride.
pHá791ñ: between 4.0and 6.5.
Other requirements— It meets the requirements under Injections á1ñ.
Assay
pH6.8Phosphate buffer— Dissolve 1.94g of monobasic potassium phosphate and 2.48g of dibasic potassium phosphate in 1000mLof water.Adjust,if necessary,with 1Npotassium hydroxide or 1Mphosphoric acid to a pHof 6.8.
Mobile phase— Prepare a fresh solution of acetonitrile and pH6.8Phosphate buffer(65:35).Adjust,if necessary,with 1Mphosphoric acid to a pHof 7.7±0.2.Filter the solution through a membrane filter of 1-µm or finer porosity,and degas.
Internal standard solution— Prepare a solution of dibutyl phthalate in methanol containing about 1.3mg per mL.
Standard preparation— Dissolve about 50mg of USP Bupivacaine Hydrochloride RS,accurately weighed,in 10.0mLof water,using sonication if necessary,in a 100-mLvolumetric flask.Add 10mLof Internal standard solution,dilute with methanol to volume,and mix.
Assay preparation— Transfer an accurately measured volume of Injection,equivalent to about 50mg of bupivacaine hydrochloride,to a 100-mLvolumetric flask,add 10.0mLof Internal standard solution,dilute with methanol to volume,and mix.
Chromatographic system (see Chromatography á621ñ)—The liquid chromatograph is equipped with a 263-nm detector and a 4-mm ×30-cm column that contains packing L1.The flow rate is about 2mLper minute.Chromatograph three replicate injections of the Standard preparation,and record the peak responses as directed for Procedure:the relative standard deviation of the ratios of the bupivacaine hydrochloride peak to the dibutyl phthalate peak is not more than 1.0%,and the resolution R,factor,between bupivacaine hydrochloride and dibutyl phthalate is not less than 2.0.
Procedure— Separately inject equal volumes (about 20µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.The relative retention times are about 1.2for dibutyl phthalate and 1.0for bupivacaine hydrochloride.Calculate the quantity,in mg,of C18H28N2O·HCl in the volume of Injection taken by the formula:
W(RU/RS),
in which Wis the weight,in mg,of USP Bupivacaine Hydrochloride RS,calculated on the anhydrous basis,in the Standard preparation,and RUand RSare the ratios of the peak responses of bupivacaine hydrochloride to those of the internal standard obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Karen A Russo,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28–NF23Page 293
Phone Number:1-301-816-8379